01 1Formosa Laboratories
01 1ERIBULIN MESYLATE
01 1Taiwan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-29
Pay. Date : 2021-09-28
DMF Number : 35358
Submission : 2020-11-30
Status : Active
Type : II
20
Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ERIBULIN MESYLATE, with a corresponding US DMF Number 35358.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 29, 2021, and payment made on September 28, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
